Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -8567.94% is 12% below its 4-year average of -7669.09%, near the high end of its 4-year range (-72180.00%–-124.47%).
14.76% above its 12-month average of -10051.20%.
Reported quarterly EBITDA margin; no daily interpolation. Q1 FY2027 (2026-06-30): -15105.56%.
EBITDA MARGIN
-8567.94%
EBITDA MARGIN AVG TTM
-10051.20%
EBITDA MARGIN AVG 3Y
-9399.62%
EBITDA MARGIN AVG 5Y
-7669.09%
EBITDA MARGIN AVG 10Y
-4274.54%
EBITDA MARGIN AVG 15Y
-3485.19%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+14.76%
CURRENT VS 3Y AVG
+8.85%
CURRENT VS 5Y AVG
-11.72%
CURRENT VS 10Y AVG
-100.44%
CURRENT VS 15Y AVG
-145.84%
CURRENT VS 20Y AVG
N/A
VivoSim Labs, Inc.
Market Cap
$518606.00
EBITDA Margin
-8567.94%
TTM Avg
-10051.20%
3Y Avg
-9399.62%
5Y Avg
-7669.09%
Market Cap
$545796.00
EBITDA Margin
-18836.70%
TTM Avg
-9969.53%
3Y Avg
-5254.43%
5Y Avg
-4229.16%
Market Cap
$403887.00
EBITDA Margin
-2196.68%
TTM Avg
-1727.24%
3Y Avg
-1664.72%
5Y Avg
-2055.32%
Market Cap
$378849.00
EBITDA Margin
-47981.26%
TTM Avg
-69951.07%
3Y Avg
-52738.28%
5Y Avg
-42190.63%
Market Cap
$667469.00
EBITDA Margin
-650.71%
TTM Avg
-399.98%
3Y Avg
-297.88%
5Y Avg
-236.24%
Market Cap
$250443.00
EBITDA Margin
-994.74%
TTM Avg
-759.01%
3Y Avg
-558.46%
5Y Avg
-556.54%
Market Cap
$824550.00
EBITDA Margin
-148.44%
TTM Avg
-191.64%
3Y Avg
-1422.24%
5Y Avg
-1921.61%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| VivoSim Labs, Inc. (VIVS) | $518606.00 | -8567.94% | -10051.20% | -9399.62% | -7669.09% |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | -18836.70% | -9969.53% | -5254.43% | -4229.16% |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | N/A | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | -2196.68% | -1727.24% | -1664.72% | -2055.32% |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | -47981.26% | -69951.07% | -52738.28% | -42190.63% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | -650.71% | -399.98% | -297.88% | -236.24% |
| CDT Equity Inc. (CDT)vs › | $716854.00 | N/A | N/A | N/A | N/A |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | -994.74% | -759.01% | -558.46% | -556.54% |
| Decoy Therapeutics Inc. (DCOY)vs › | $824550.00 | -148.44% | -191.64% | -1422.24% | -1921.61% |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | -1.14% | 1.51% | -2.34% | -2.59% |
Gross Margin
100.0%
EBITDA Margin
-8567.9%
Operating Margin
-8567.9%
Net Margin
-11016.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -15105.56% |
| 2026-03-31 | -7860.00% |
| 2025-12-31 | -10376.92% |
| 2025-09-30 | -9200.00% |
| 2025-06-30 | -7713.51% |
| 2025-03-31 | -6064.71% |
| 2024-12-31 | -14170.83% |
| 2024-09-30 | -8466.67% |
| 2024-06-30 | -8502.56% |
| 2024-03-31 | -10431.03% |
| 2023-12-31 | -72180.00% |
| 2023-06-30 | -5504.00% |
| 2023-03-31 | -4765.43% |
| 2022-12-31 | -2464.89% |
| 2022-09-30 | -4285.71% |
| 2022-03-31 | -124.47% |
| 2019-12-31 | -1502.35% |
| 2019-09-30 | -540.89% |
| 2019-06-30 | -945.51% |
| 2019-03-31 | -1030.29% |
| 2018-12-31 | -805.13% |
| 2018-09-30 | -607.32% |
| 2018-06-30 | -1057.91% |
| 2018-03-31 | -658.64% |
| 2017-12-31 | -658.63% |
| 2017-09-30 | -683.25% |
| 2017-06-30 | -997.37% |
| 2017-03-31 | -1276.23% |
| 2016-12-31 | -808.77% |
| 2016-09-30 | -670.64% |
| 2016-06-30 | -956.90% |
| 2016-03-31 | -1491.97% |
| 2015-12-31 | -3120.12% |
| 2015-09-30 | -3686.05% |
| 2015-06-30 | -2719.93% |
| 2015-03-31 | -2933.33% |
| 2014-12-31 | -4409.68% |
| 2014-09-30 | -17688.00% |
| 2014-06-30 | -6377.78% |
| 2014-03-31 | -5727.83% |
| 2013-12-31 | -3354.07% |
| 2013-09-30 | -23934.78% |
| 2013-06-30 | -3434.91% |
| 2013-03-31 | -1834.88% |
| 2012-12-31 | -815.49% |
| 2012-09-30 | -754.33% |
| 2012-06-30 | -551.38% |
| 2012-03-31 | -1093.33% |
| 2011-09-30 | -1398.03% |
